Everolimus Modulation of Anti-tumor T CD4 Immune Responses
NCT02837757
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class
Stopped
difficulty of patient recruitment
Conditions
Metastatic Renal Cancer
Interventions
OTHER:
Biological samples
Sponsor
Centre Hospitalier Universitaire de Besancon